Recall Monitor
Health Products

CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde is out of specification in the affected lots.

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Drugs
Product: CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
Issue: Health products - Product quality
What to do: Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Audience: General public, Healthcare, Industry
Recall class: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

BrandProduct nameMarket AuthorizationDosage FormStrengthLot
CISATRACURIUM BESYLATE INJECTION USP MULTIDOSECISATRACURIUM BESYLATE INJECTION USP MULTIDOSEDIN 02408813SolutionCisatracurium (Cisatracurium besilate) 2mg/mlB3L78VA, B3M79VA

Issue

The level of the degradation product Benzaldehyde is out of specification in the affected lots.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime